Concepedia

Heidi Baum

HB

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2007

Affiliations

Pfizer (United States)(Current)

Heidi Baum is an author at Pfizer (United States) specializing in drug discovery, medicine, and pharmacotherapy.

Top concepts

Publications per year

2007–2013

3

Publications

3

N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain

Christopher Deur, Arun K. Agrawal, Heidi Baum et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 24 citations · Full text

, , +12

Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, Part I: Transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitors

Mark S. Plummer, Joseph A. Cornicelli, Howard Roark et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 18 citations · Full text

, , +10

Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: Optimization studies and demonstration of in vivo efficacy

Mark S. Plummer, Joseph A. Cornicelli, Howard Roark et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 15 citations · Full text

, , +9

1–3 of 3